Cordero-Escobar I

Language: Spanish
References: 16
Page: 114-119
PDF size: 166.79 Kb.

ABSTRACT

Introduction: Neuromuscular diseases are unusual; however, it is not so strange that some patients enter the operating room for the practice of diagnosis studies in order to receive some anesthetic-surgical procedure due to some of its complications or for interventions without any kind of relationship with its basic disease. Objectives: To identify the clinical manifestations of neuromuscular diseases, as well as the anesthetic performance in those patients. Development: It was carried out a literature review on the mentioned topic, which embraced the set of problems around neuromuscular diseases in order to define the anesthetic treatment over those patients. Conclusions: Anesthesiologists should know the pathogenesis of neuromuscular diseases and their consequences through the use of different anesthetic techniques, the actions to be taken during the postoperative period, as well as the kinetics and dynamics of the intended drugs to be used, in order to avoid complications.

REFERENCES

1. González MJ, Cordero EI, Ortega JL, Gómez C. Anestesia en miastenia gravis y enfermedades neuromusculares. En: Luis M Torres. Tratado de Anestesia y Reanimación Madrid, Ed Arán 2001. pp. 1829-1839.

2. Diendorf SF. Anestesia for patients with rare and coexisting disease. In: Clinical anesthesia. Barash PG, Stoelting RK. Lippincott-Raven 3rd Edition. Philadelphia 1997. pp. 461-466.

3. Naguib M, Flood P, McArdle JJ, Brenner HR. Advances in neurobiology of the neuromuscular junction. Implications for the anesthesiologist. Anesthesiology 2002;96:23-51.

4. Boonyapisit K, Kaminski HJ, Ruff RL. Disorders of neuromuscular junction ion channels. Am J Med 1999;106:97-113.

5. Duchen LW. Clasificación de las enfermedades neuromusculares. [En línea]. [Consulta: 20 de enero del 2005]. URL disponible En: http://neuromuscular.com.ar/transmision.htm.

6. Mora M, Lambert E, Engel A. Neuromuscular disease. [En línea]. [Consulta: 20 enero 2005]. URL disponible En: http://neuromuscular.com.ar/htm.

7. Walls T J, Engel A. Neuromuscular disease. [En línea]. [Consulta: 20 enero de 2005]. URL disponible En: http://neuromuscular.com.ar/transmision.htm

8. Nagel A G. Síndrome de Lambert Eaton. Ann Neurol 1998;24:552.

9. Engel A G. Myasthenc Syndrome. Arch Neurol 1999;56:163-167. [En línea]. [Consulta: 20 enero del 2005]. URL disponible En: http://neuromuscular.com.ar/transmision.htm.

10. Lobos E A. Congenital Myasthenic Syndrome. [En línea]. [Consulta: 20 de enero del 2005]. URL disponible En: http://neuromuscular.com.ar/transmision.htm.

11. Hutchinson D O. Deficiencia de AchE. [En línea]. [Consulta: 20 de enero del 2005]. URL disponible En http://neuromuscular.com.ar/transmision.htm.

12. Ohno K. Slowly channel and SMC. Neurology 2000; 54 suppl. [En línea]. [Consulta: 20 enero 2005] URL disponible En: http://neuromuscular.com.ar/transmision.htm.

13. Illa S I. Miastenia gravis. [En línea]. [Consulta: 20 de enero del 2005]. URL disponible En: http://www.bcm.edu/neurol/research/nmus/html.

14. Cordero E I, Parisi LN. Relajantes musculares en los pacientes miasténicos. En: Álvarez GJA, González MF. Bustamante BR. Relajantes musculares en anestesia y terapia intensiva. Cap 47. 2da ed. ELA. Madrid. 2000. pp. 613-619.

15. Cordero EI, Parisi LN, Espinaco VJ. ¿Qué dosis de cisatracurio usar en los miasténicos quirúrgicos? Rev Mex Anest 2004;27:205-209.

16. Cordero EI, Parisi LN, Benítez TSM. Miastenia y mivacurio para la timectomía transesternal. Rev Esp Anest Rean 2002;49:360-364.